Department of Physical Medicine and Rehabilitation & Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
J Pediatr Rehabil Med. 2023;16(1):11-17. doi: 10.3233/PRM-230001.
Baclofen is often considered a first-line treatment option for spasticity management in children. However, adverse effects, administration, and dosing can be barriers to effectiveness. In my practice, other medications for spasticity management are often used prior to initiating baclofen. In this article, baclofen use for spasticity management in children is briefly reviewed along with discussion of approaches using other medications as first-line treatment options. I will present a rationale for medication selection for spasticity management and discuss the approaches I take in medication selection that incorporate spasticity severity, patient goals, and medication side effect profiles.
巴氯芬通常被认为是治疗儿童痉挛的一线治疗选择。然而,不良反应、给药和剂量可能会成为影响疗效的障碍。在我的临床实践中,在开始使用巴氯芬之前,通常会先使用其他药物来治疗痉挛。本文简要回顾了巴氯芬在儿童痉挛管理中的应用,并讨论了将其他药物作为一线治疗选择的方法。我将提出痉挛管理药物选择的理由,并讨论我在药物选择中采用的方法,包括痉挛严重程度、患者目标和药物副作用特征。